Letrozole combined with norethisterone acetate compared with norethisterone acetate alone in the treatment of pain symptoms caused by endometriosis
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The available data on effectiveness of aromatase inhibitors in treating pain symptoms related to endometriosis is limited. We compared the efficacy and tolerability of the aromatase inhibitor letrozole combined with norethisterone acetate versus norethisterone acetate alone in treating pain symptoms. METHODS: This prospective, open-label, non-randomized trial included 82 women with pain symptoms caused by rectovaginal endometriosis. Patients received either a combination of letrozole and norethisterone acetate (group L) or norethisterone acetate alone (group N) for 6 months. Changes in pain symptoms during treatment and in the 12 months of follow-up were evaluated. Side effects of each treatment protocol were recorded. RESULTS: Intensity of chronic pelvic pain and deep dyspareunia significantly decreased during treatment (P < 0.001 versus baseline by 3 months) in both study groups. At both 3- and 6-month assessment, the intensity of chronic pelvic pain (P < 0.001, P = 0.002, respectively) and deep dyspareunia (P < 0.001, P = 0.005, respectively) was significantly lower in group L than group N. At completion of treatment, 63.4% of women in group N were satisfied with treatment compared with 56.1% in group L (P = 0.49). Pain symptoms recurred after the completion of treatment; at 6-month follow-up no difference was observed in the intensity of pain symptoms between the groups. Adverse effects were more frequent in group L than in group N (P = 0.02). CONCLUSIONS: The combination drug regimen was more effective in reducing pain and deep dyspareunia than norethisterone acetate; however, letrozole caused a higher incidence of adverse effects, cost more and did not improve patients' satisfaction or influence recurrence of pain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Giudice, L. C., & Kao, L. C. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17403-5 · Cited by 3,166
Aromatase expression in endometriosis.
Noble, L. S., Simpson, E. R., Johns, A., & Bulun, S. E. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550748 · Cited by 566 · cited 1×
“Since the late 1990s, several studies using either PCR or immunohistochemistry demonstrated the expression of aromatase P450 in both eutopic and ectopic endometrium from patients with endometriosis, but not in eutopic endometrium from disease-free women and in endometriosis-free peritoneal tissue (Noble et al., 1996;…”
BackgroundKitawaki, J., Noguchi, T., Amatsu, T., Maeda, K., Tsukamoto, K., Yamamoto, T., Fushiki, S., Osawa, Y., & Honjo, H. (1997) · Biology of Reproduction · doi:10.1095/biolreprod57.3.514 · Cited by 305
Treatment of severe postmenopausal endometriosis with an aromatase inhibitor
Takayama, K., Zeitoun, K., Gunby, R. T., Sasano, H., Carr, B. R., & Bulun, S. E. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00022-3 · Cited by 270
Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target
Zeitoun, K. M., & Bulun, S. E. (1999) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00393-3 · Cited by 256
Soysal, S. (2004) · Human Reproduction · doi:10.1093/humrep/deh035 · Cited by 227 · cited 1×
“, 2004; Shippen and West, 2004) or as a post-operative prevention of recurrence (Soysal et al., 2004).”
BackgroundVercellini, P., Pietropaolo, G., De Giorgi, O., Pasin, R., Chiodini, A., & Crosignani, P. G. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.03.083 · Cited by 197 · cited 4×
“They were told that norethisterone acetate might cause irregular uterine bleeding, weight increase and decreased libido (Vercellini et al., 2005).”
BackgroundResultInfluentialInflammatory Status Influences Aromatase and Steroid Receptor Expression in Endometriosis
Bukulmez, O., Hardy, D. B., Carr, B. R., Word, R. A., & Mendelson, C. R. (2008) · Endocrinology · doi:10.1210/en.2007-0665 · Cited by 186 · cited 1×
“Since the late 1990s, several studies using either PCR or immunohistochemistry demonstrated the expression of aromatase P450 in both eutopic and ectopic endometrium from patients with endometriosis, but not in eutopic endometrium from disease-free women and in endometriosis-free peritoneal tissue (Noble et al., 1996;…”
BackgroundDonnez, J., Nisolle, M., Casanas-Roux, F., Bassil, S., & Anaf, V. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136001 · Cited by 175
Medical treatment for rectovaginal endometriosis: what is the evidence?
Vercellini, P., Crosignani, P. G., Somigliana, E., Berlanda, N., Barbara, G., & Fedele, L. (2009) · Human Reproduction · doi:10.1093/humrep/dep231 · Cited by 144
Research works printed but not linked: 32
- Ailawadi, 2004, Fertility and sterility, 81, 290, 10.1016/j.fertnstert.2003.09.029 · DOI · Paper page
- Amsterdam, 2005, Fertility and sterility, 84, 300, 10.1016/j.fertnstert.2005.02.018 · DOI · Paper page
- Biscaldi, 2007, European radiology, 17, 211, 10.1007/s00330-006-0364-5 · DOI
- Biscaldi, 2009, Fertility and sterility, 91, 278, 10.1016/j.fertnstert.2008.02.131 · DOI
- Burstein, 2007, Breast (Edinburgh, Scotland), 16, 223, 10.1016/j.breast.2007.01.011 · DOI · Paper page
- Carlini, 2003, Annals of Oncology, 14, 1689, 10.1093/annonc/mdg444 · doi:10.1093/annonc/mdg444
- 2009, Human Reproduction, 24, 2133, 10.1093/humrep/dep199 · DOI · Paper page
- 2009, Journal of Clinical Endocrinology & Metabolism, 94, 876, 10.1210/jc.2008-2218 · DOI · Paper page
- de Ziegler, 2005, The Journal of steroid biochemistry and molecular biology, 95, 121, 10.1016/j.jsbmb.2005.04.023 · DOI
- Donnez, 1995, Human Reproduction, 10, 630, 10.1093/humrep/ · doi:10.1093/humrep/
- Fatemi, 2005, Reproductive biomedicine online, 11, 455, 10.1016/S1472-6483(10)61140-6 · DOI
- Felson, 2005, Arthritis and rheumatism, 52, 2594, 10.1002/art.21364 · DOI · Paper page
- Zeng, 2005, Obstetrical & gynecological survey, 60, 817, 10.1097/01.ogx.0000189153.87365.dc · DOI · Paper page
- Ferrero, 2009, Drugs, 69, 943, 10.2165/00003495-200969080-00001 · DOI
- Ford, 2004, BJOG : an international journal of obstetrics and gynaecology, 111, 353, 10.1111/j.1471-0528.2004.00093.x · DOI · Paper page
- Gurates, 2008, Reproductive biomedicine online, 17, 569, 10.1016/S1472-6483(10)60246-5 · DOI
- Hefler, 2005, Fertility and sterility, 84, 1033, 10.1016/j.fertnstert.2005.04.059 · DOI
- Kitawaki, 1999, Fertility and sterility, 72, 1100, 10.1016/S0015-0282(99)00424-0 · DOI
- Mousa, 2007, Obstetrics & Gynecology, 109, 1421, 10.1097/01.AOG.0000265807.19397.6d · DOI · Paper page
- Muneyyirci-Delale, 1998, International journal of fertility and women's medicine, 43, 24
- Noble, 1996, Journal of Clinical Endocrinology & Metabolism, 81, 174, 10.1210/jc.81.1.174 · DOI · Paper page
- Razzi, 2004, BJOG : an international journal of obstetrics and gynaecology, 111, 182, 10.1046/j.1471-0528.2003.00038.x · DOI · Paper page
- Remorgida, 2007, Fertility and sterility, 88, 724, 10.1016/j.fertnstert.2006.12.027 · DOI
- Remorgida, 2007, The Australian & New Zealand journal of obstetrics & gynaecology, 47, 222, 10.1111/j.1479-828X.2007.00722.x · DOI · Paper page
- Riis, 2002, American journal of obstetrics and gynecology, 187, 1101, 10.1067/mob.2002.122852 · DOI
- Sestak, 2008, The lancet oncology, 9, 866, 10.1016/S1470-2045(08)70182-7 · DOI · Paper page
- Shippen, 2004, Fertility and sterility, 81, 1395, 10.1016/j.fertnstert.2003.11.027 · DOI
- Slack, 2007, BJOG : an international journal of obstetrics and gynaecology, 114, 1278, 10.1111/j.1471-0528.2007.01477.x · DOI · Paper page
- Menada, 2008, Fertility and sterility, 89, 699, 10.1016/j.fertnstert.2007.07.1336 · DOI
- 2008, Human Reproduction, 23, 1069, 10.1093/humrep/den057 · DOI · Paper page
- Verma, 2009, European journal of obstetrics, gynecology, and reproductive biology, 143, 112, 10.1016/j.ejogrb.2008.12.002 · DOI
- 2005, Human Reproduction, 20, 1702, 10.1093/humrep/deh796 · DOI · Paper page
Cited by
Endometriosis: pathogenesis and treatment
Vercellini, P., Viganò, P., Somigliana, E., & Fedele, L. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.255 · Cited by 1,940
Systematic review of endometriosis pain assessment: how to choose a scale?
Bourdel, N., Alves, J., Pickering, G., Ramilo, I., Roman, H., & Canis, M. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmu046 · Cited by 372
Clinical Management of Endometriosis
Falcone, T., & Lebovic, D. I. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e31822adfd1 · Cited by 263
Estrogen-progestins and progestins for the management of endometriosis
Vercellini, P., Buggio, L., Berlanda, N., Barbara, G., Somigliana, E., & Bosari, S. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.10.022 · Cited by 243
The direct and indirect costs associated with endometriosis: a systematic literature review
Soliman, A. M., Yang, H., Du, E. X., Kelley, C., & Winkel, C. (2016) · Human Reproduction · doi:10.1093/humrep/dev335 · Cited by 239
Bowel endometriosis: Diagnosis and management
Nezhat, C., Li, A., Falik, R., Copeland, D., Razavi, G., Shakib, A., Mihailide, C., Bamford, H., DiFrancesco, L., Tazuke, S., et al. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.09.023 · Cited by 205
“Leuprolide acetate, a gonadotropin-releasing hormone agonist, can also helpmitigate symptoms in women with rectovaginal endometriosis and can be used with add-back norethindrone therapy.(35) Leuprolide can also be useful preoperatively to decrease disease burden at the time of surgery.”
MethodMedical treatment of endometriosis-related pain
Vercellini, P., Buggio, L., Frattaruolo, M. P., Borghi, A., Dridi, D., & Somigliana, E. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.01.015 · Cited by 188
“Waiting for Godot”: a commonsense approach to the medical treatment of endometriosis
Vercellini, P., Crosignani, P., Somigliana, E., Vigano, P., Frattaruolo, M. P., & Fedele, L. (2011) · Human Reproduction · doi:10.1093/humrep/deq302 · Cited by 180
“This finding has prompted performance of several pilot studies in women with endometriosis using one of the two available reversible aromatase inhibitors (i.e. anastrozole and letrozole), which compete with androgens for aromatase-binding sites (Patwardhan et al., 2008; Ferrero et al., 2009a).”
BackgroundInfluentialReis, F. M., Coutinho, L. M., Vannuccini, S., Batteux, F., Chapron, C., & Petraglia, F. (2020) · Human Reproduction Update · doi:10.1093/humupd/dmaa009 · Cited by 166
Aromatase inhibitors for the treatment of endometriosis
Pavone, M. E., & Bulun, S. E. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.08.053 · Cited by 138
“However, pain symptoms recurred in both groups after completion of therapy and by six months, there was no difference in the intensity of pain symptoms between the groups (51).”
BackgroundVercellini, P., Somigliana, E., Consonni, D., Frattaruolo, M. P., De Giorgi, O., & Fedele, L. (2012) · Human Reproduction · doi:10.1093/humrep/des313 · Cited by 129
Vercellini, P., Bracco, B., Mosconi, P., Roberto, A., Alberico, D., Dhouha, D., & Somigliana, E. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.11.016 · Cited by 127
Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review
Ferrero, S., Gillott, D. J., Venturini, P. L., & Remorgida, V. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-89 · Cited by 109
“peer-reviewed journals between 2004 and October 2010 [38-47].”
BackgroundResultInfluentialSelf-citationNorethisterone acetate in the treatment of colorectal endometriosis: a pilot study
Ferrero, S., Camerini, G., Ragni, N., Venturini, P. L., Biscaldi, E., & Remorgida, V. (2010) · Human Reproduction · doi:10.1093/humrep/dep361 · Cited by 107
Self-citationVercellini, P., Frattaruolo, M. P., Somigliana, E., Jones, G. L., Consonni, D., Alberico, D., & Fedele, L. (2013) · Human Reproduction · doi:10.1093/humrep/det041 · Cited by 97
“Total FSFI scores, anxiety and depression scores and EHP-30 scores improved immediately after surgery, but worsened with time, whereas the effect during progestin use increased more gradually, but progressively, without overall significant between-group differences at 12-month follow-up.”
InfluentialHormonal therapy for endometriosis: from molecular research to bedside
Tosti, C., Biscione, A., Morgante, G., Bifulco, G., Luisi, S., & Petraglia, F. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2016.05.032 · Cited by 96
Morotti, M., Sozzi, F., Remorgida, V., Venturini, P. L., & Ferrero, S. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.10.036 · Cited by 84
Self-citationLeone Roberti Maggiore, U., Remorgida, V., Scala, C., Tafi, E., Venturini, P. L., & Ferrero, S. (2014) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/aogs.12326 · Cited by 80
Self-citationLetrozole and norethisterone acetate in colorectal endometriosis
Ferrero, S., Camerini, G., Ragni, N., Venturini, P. L., Biscaldi, E., Seracchioli, R., & Remorgida, V. (2010) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.02.023 · Cited by 80
Self-citationSafety of medical treatments for endometriosis
Berlanda, N., Somigliana, E., Viganò, P., & Vercellini, P. (2016) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1121991 · Cited by 78
A comprehensive review of hormonal and biological therapies for endometriosis: latest developments
Barra, F., Grandi, G., Tantari, M., Scala, C., Facchinetti, F., & Ferrero, S. (2019) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2019.1581761 · Cited by 69
Self-citationFrom pathogenesis to clinical practice: Emerging medical treatments for endometriosis
Clemenza, S., Sorbi, F., Noci, I., Capezzuoli, T., Turrini, I., Carriero, C., Buffi, N., Fambrini, M., & Petraglia, F. (2018) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2018.01.021 · Cited by 63
A stepped-care approach to symptomatic endometriosis management: A participatory research initiative
Vercellini, P., Donati, A., Ottolini, F., Frassineti, A., Fiorini, J., Nebuloni, V., Frattaruolo, M. P., Roberto, A., Mosconi, P., & Somigliana, E. (2018) · Fertility and Sterility · doi:10.1016/j.fertnstert.2018.01.037 · Cited by 64
Role of medical therapy in the management of deep rectovaginal endometriosis
Vercellini, P., Buggio, L., & Somigliana, E. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.08.038 · Cited by 62
New trends for the medical treatment of endometriosis
Rocha, A. L. L., Reis, F. M., & Petraglia, F. (2012) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2012.683783 · Cited by 60
Morotti, M., Venturini, P. L., Biscaldi, E., Racca, A., Calanni, L., Vellone, V. G., Stabilini, C., & Ferrero, S. (2017) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2017.03.033 · Cited by 43
Self-citationUse of Norethindrone Acetate Alone for Postoperative Suppression of Endometriosis Symptoms
Kaser, D. J., Missmer, S. A., Berry, K. F., & Laufer, M. R. (2012) · Journal of Pediatric and Adolescent Gynecology · doi:10.1016/j.jpag.2011.09.013 · Cited by 42
Triptorelin improves intestinal symptoms among patients with colorectal endometriosis
Ferrero, S., Camerini, G., Ragni, N., Menada, M. V., Venturini, P. L., & Remorgida, V. (2010) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.09.028 · Cited by 37
Self-citationA peek into the drug development scenario of endometriosis – A systematic review
Goenka, L., George, M., & Sen, M. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.092 · Cited by 37
Management of endometriosis: Toward value-based, cost-effective, affordable care
Vercellini, P., Facchin, F., Buggio, L., Barbara, G., Berlanda, N., Frattaruolo, M. P., & Somigliana, E. (2018) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2017.07.011 · Cited by 36
Diagnosis and treatment of rectovaginal endometriosis: an overview
KRUSE, C., SEYER‐HANSEN, M., & FORMAN, A. (2012) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.1111/j.1600-0412.2012.01367.x · Cited by 26
Mercorio, A., Giampaolino, P., Romano, A., Dällenbach, P., & Pluchino, N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.950866 · Cited by 16
“The combination of letrozole plus NETA showed a TABLE 2 Expression (protein levels), enzymatic activity of aromatase in endometriotic lesions and correlation with disease characteristics, eutopic and healty endometrium.”
BackgroundInfluentialCsirzó, Á., Kovács, D. P., Szabó, A., Szabó, B., Jankó, Á., Hegyi, P., Nyirády, P., Ács, N., & Valent, S. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13226932 · Cited by 16
Metadata
- Authors
- Ferrero, S., Camerini, G., Seracchioli, R., Ragni, N., Venturini, P. L., & Remorgida, V.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-09-02
- Volume
- 24
- Issue
- 12
- Pages
- 3033-3041
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2157853773
- Cited by
- 134
- References
- 17
- FWCI
- 12.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.